Core Insights - The stock price of Dian Diagnostics (300244) closed at 16.1 yuan on July 31, 2025, with an increase of 1.58% and a turnover rate of 7.57% [1] - The company reported a total revenue of 2.365 billion yuan for Q1 2025, a year-on-year decrease of 20.45%, and a net profit of 21.01 million yuan, down 190.66% year-on-year [1] Financial Performance - Total revenue for Q1 2025: 2.365 billion yuan, down 20.45% year-on-year [1] - Net profit: 21.01 million yuan, down 190.66% year-on-year [1] - Non-recurring net profit: 26.31 million yuan, down 211.77% year-on-year [1] - Current ratio: 2.650, Quick ratio: 2.271, Debt-to-asset ratio: 42.54% [1] Market Activity - Main capital inflow on the reporting day was 27.10 million yuan, accounting for 4.4% of the total transaction amount [1] - Large orders saw a net inflow of 23.31 million yuan, representing 3.78% of the transaction amount [1] - Medium and small orders experienced net outflows of 15.35 million yuan and 11.75 million yuan, respectively [1] Company Background - Dian Diagnostics Technology Group Co., Ltd. was established in 2001 and is located in Hangzhou [2] - The company has a registered capital of 6.25 billion yuan and has made investments in 41 enterprises [2] - The company holds 184 trademark registrations and 8 patents, along with 36 administrative licenses [2]
迪安诊断(300244)7月31日主力资金净流入2710.14万元